DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Ind Swift Laboratories Lt (INDSWFTLAB) share price today?

Ind Swift Laboratories Lt (INDSWFTLAB) is trading at ₹357 on the NSE, down 3.44% on the day. Source: DocStoX.

What is the PE ratio of Ind Swift Laboratories Lt?

Ind Swift Laboratories Lt has a price-to-earnings (PE) ratio of 74.8 in the Healthcare sector.

What is the market capitalisation of Ind Swift Laboratories Lt?

Ind Swift Laboratories Lt has a market capitalisation of approximately ₹3,124 crore.

Is Ind Swift Laboratories Lt a profitable company?

Ind Swift Laboratories Lt generates a return on equity of 0.0% with a net profit margin of 6.5%. That is a modest return on shareholder capital.

What is the 52-week high and low of INDSWFTLAB?

Ind Swift Laboratories Lt (INDSWFTLAB) has traded between ₹87.15 and ₹424.75 over the past 52 weeks, against a current price of ₹357.

IND Swift Laboratories LT

₹357.00▼ -12.70 (-3.44%)

INDSWFTLAB·NSE·Healthcare

Market Cap

3124.09 Cr

PE Ratio

74.84

Volume

2,62,152

Day High - Low

377.20 - 355.00

52W High-Low

424.75 - 87.15

₹357.00▼ -12.70 (-3.44%)

Market Cap3124.09 Cr

PE Ratio74.84

Volume2,62,152

Day High - Low377.20 - 355.00

52W High-Low424.75 - 87.15

Ind Swift Laboratories Lt (INDSWFTLAB): company summary

Annual revenue rose 14.1% to ₹641 crore, but annual net profit fell 83.4% to ₹41 crore.

Ind Swift Laboratories Lt (INDSWFTLAB) is a micro-cap Healthcare company valued at ₹3,124 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Ind Swift Laboratories Lt last traded at ₹357, down 3.44% on the day.
Recent developments: On 2026-09-30, promoter holding remained at 42.93%, with foreign institutional holding increasing by 0.20 percentage points to 10.90%. Domestic institutional holding stayed at 0.15%.
Financial performance: Annual revenue rose 14.1% to ₹641 crore, but annual net profit fell 83.4% to ₹41 crore. The latest quarter saw revenue rise 25.1% to ₹191 crore and net profit jump 174.2% to ₹25 crore, showing a sharp improvement in the most recent period compared to the same quarter a year earlier.
Valuation multiples: The stock trades at 74.8 times earnings, a premium to the Healthcare median of 32.0, 2.37 times book value.
Things to watch: Net profit margin fell 38.0 percentage points to 6.5%, and return on equity is 0.0%. The company is not paying out dividends despite reporting profits.
Where it stands: The company's latest quarter showed a significant rise in net profit, but annual net profit fell sharply. The most recent figure is net profit of ₹25 crore, up 174.2% from the same quarter a year earlier.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

3.3/10

Poor

Fair Value

ROE

0.00%

Weak

P/E

74.84x

Expensive

Debt / Equity

0.01

Low

Industry

Healthcare

Pharmaceuticals

Overall View

Mixed

Price performance

Day₹355.00

₹377.20

52W₹87.15

₹424.75

DocStoX take

Supported by momentum (7.5), but held back by growth (1.3). Momentum looks strong at 7.5, but that is offset by growth at 1.3 and quality at 1.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

3.3

/10

Poor

Quality

Weak

ROE 0.0%

Valuation

Rich

P/E 74.8×

Growth

Flat

Revenue -6.4% 5Y CAGR

Risk

Moderate

D/E 0.01

Momentum

Strong

80% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹357

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹3,124 Cr

52W High / Low

₹425 / ₹87

Dividend Yield

0.00%

Promoter Holding

42.93%

EPS (TTM)

₹4.77

Book Value

₹159.38

Key highlights

Low leverage — D/E 0.01
Profit shrinking 5% a year
Revenue shrinking 6% a year

1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore IND SWIFT LABORATORIES LT’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

IND SWIFT LABORATORIES LT peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare IND SWIFT LABORATORIES LT with peers

IND SWIFT LABORATORIES LT vs Sun Pharmaceutical Industries Limited IND SWIFT LABORATORIES LT vs Divi's Laboratories Limited IND SWIFT LABORATORIES LT vs Torrent Pharmaceuticals Limited IND SWIFT LABORATORIES LT vs Apollo Hospitals Enterprise Limited IND SWIFT LABORATORIES LT vs Zydus Lifesciences Limited IND SWIFT LABORATORIES LT vs Laurus Labs Limited

Related tools & concepts

Value IND SWIFT LABORATORIES LT with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

INDSWFTLAB newsLatest coverage & filings Open screenerFilter the whole market